在骨髓瘤肺转移中涉及的病理生物学和分子途径:一个范围审查
Ala Bashir1, Ayden Ismail2, Avenie Mavadia3
1Worcestershire Acute Hospitals NHS Trust, Worcestershire, UK.
Technology in cancer research & treatment
|July 18, 2025
概括
骨髓瘤转移是由瘤细胞的变化和瘤微环境所驱动的. 准细胞内和免疫路径可能会减轻传播,但需要对休眠和组合疗法的更多研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤 (OS) 是最常见的原发性骨癌.
- 肺转移是OS患者死亡的主要原因.
- 转移包括复杂的瘤细胞适应,免疫调节和休眠.
研究的目的:
- 审查OS转移中被忽视和研究不足的途径.
- 支持现有的治疗目标,并确定新的治疗目标.
- 为了指导未来的研究OS转移.
主要方法:
- 根据PRISMA-ScR指南进行范围审查.
- 从2019年开始搜索了MEDLINE,Embase和Cochrane CENTRAL.从2019年开始搜索了MEDLINE,Embase和Cochrane CENTRAL.从2019年开始搜索了MEDLINE,Embase和Cochrane CENTRAL.从2019年开始搜索了Medline,Embase和Cochrane CENTRAL.从2019年开始搜索了Medline,Embase和Cochrane CENTRAL.从2019年开始搜索了Medline,Embase和Cochrane CENTRAL.从2019年开始搜索了Medline,Embase和Cochrane CENTRAL.
- 包括43份报告:30个体内,8个体外,5个观察性研究.
主要成果:
- 瘤细胞的适应,如EMT和JAK/STAT/TGF-β信号驱动肺转移.
- 瘤微环境,包括与瘤相关的巨细胞/中性粒细胞,促进了转移前的形成.
- 肺休眠将瘤和免疫机制联系在一起,炎症途径可能会逆转它.
结论:
- 针对细胞内信号和免疫路径可以减轻OS转移.
- 瘤相关巨细胞的双重作用需要进一步研究.
- 综合方法和组合疗法对于确切的结果至关重要,特别是在肺休眠期.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


